Phase 2/3 Clinical Trial Results: Safety &amp; Efficacy Results of RT001, a site-specific (C11) di-deutero synthetic homologue of linoleic acid, in Infantile Neuroaxonal Dystrophy

RT001 - Retrotope

Alexander Fay1; Darius Adams2; Paldeep Atwal3; Frederic Heerinckx3; Mark Midei3; Peter Milner3

Mar 6, 2022